Open AccessAre antipsychotics effective adjunctive Tx for patients with moderate-to-severe depression?
Author(s) -
Bleacher
Publication year - 2022
Publication title -
the journal of family practice
Language(s) - English
DOI - 10.12788/jfp.0445
Subject(s) - medicine , ziprasidone , quetiapine , aripiprazole , olanzapine , discontinuation , randomized controlled trial , serotonin reuptake inhibitor , antidepressant , adverse effect , depression (economics) , psychiatry , schizophrenia (object oriented programming) , macroeconomics , hippocampus , economics